The courtroom proceedings continue regarding Luigi Mangione, who has been charged in connection with the December 4, 2024, death of UnitedHealthcare CEO Brian Thompson. Mangione, 27, has pleaded not guilty to multiple charges. The pretrial hearing, which was delayed after Mangione reportedly fell ill last Friday, has resumed to determine whether evidence collected during his arrest, including items found in his possession and statements made to police, will be admissible in court, according to FOX 5 New York.
Newly released evidence has added developments to the case, with state courts sharing photographs and documents over the weekend. Investigators reported that Mangione had a folding knife in his pocket and a bus ticket under the name "Sam Dawson," reportedly one of his aliases. Authorities also found a 3D-printed handgun and a notebook in his backpack, which may indicate a planned attack on a health-care executive. FOX 5 New York reports that defense attorneys argue the search that uncovered this evidence was conducted without a warrant, claiming that police cited a bomb threat.
The newly discovered items include what has been described as a "survival kit," with everyday objects such as a USB drive and a digital camera. Legal experts say the relevance of these items remains uncertain until they can be definitively connected to the crime through forensic evidence or gunshot residue. FOX 5 New York states that defense attorneys argue Mangione’s rights were violated when officers did not promptly provide Miranda warnings and searched his backpack without a warrant.
The fourth day of hearings is in progress, with potential effects on both the state case and an upcoming federal proceeding. The backpack, reportedly containing a 3D-printed weapon and writings described as incriminating, is central to the legal arguments. Defense attorneys have argued that the constitutionality of the case depends on whether the search of the backpack was lawful, according to court filings obtained by ABC7NY. Proceedings are scheduled to begin at 9:30 a.m., and the rulings could influence a federal hearing set for January 9.
